Regulation of Kidney-Specific Gene Expression
肾脏特异性基因表达的调节
基本信息
- 批准号:9318506
- 负责人:
- 金额:$ 36.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-25 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:Adenylate CyclaseAdoptedAffectAllelesAreaAutosomal Dominant Polycystic KidneyAwardC-terminalCRISPR/Cas technologyCadherinsCell Culture TechniquesCell LineCellsChIP-seqCiliaClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsComplexCongenital AbnormalityContact InhibitionCyclic AMPCyclic AMP-Dependent Protein KinasesCystCystic Kidney DiseasesCystic kidneyDNADNA BindingDevelopmentDigestionDiseaseDominant-Negative MutationDysplasiaEmbryoEpithelialEpithelial CellsEpitheliumExhibitsExonsFibrosisFosteringGLIS2 geneGene ActivationGene ExpressionGene ProteinsGene TargetingGenerationsGenesGeneticGenetic CrossesGenetic ModelsGenetic TranscriptionGenotypeGoalsGrowthHumanImmunoblot AnalysisIn VitroInstructionKidneyKidney DiseasesKidney FailureKnock-outKnockout MiceLengthMalignant NeoplasmsMammalian OviductsMeasuresMetabolismMicroRNAsMifepristoneModelingMolecular ProfilingMorphologyMothersMusMutant Strains MiceMutationNIH 3T3 CellsNamesNucleotidesNull LymphocytesOrganOther GeneticsPKD2 proteinPathogenesisPathogenicityPathway AnalysisPathway interactionsPhenotypePhosphorylationPhysiologyPlasmidsPlayProgress ReportsProteinsPublishingQuantitative Reverse Transcriptase PCRReagentRegulationRenal functionReverse Transcriptase Polymerase Chain ReactionRoleSeveritiesSignal TransductionSiteSouthern BlottingStructureTCF3 geneTestingTimeTissue-Specific Gene ExpressionTissuesTranscriptional ActivationUMOD geneUntranslated RNAUp-RegulationWNT Signaling PathwayWorkbasec newc-myc Genesgenetic manipulationgenome-widehepatic nuclear factor 1hepatocyte nuclear factorimprovedkidney cellknock-downlipid metabolismloss of function mutationmigrationmouse modelmutantnephrogenesisnew therapeutic targetnoveloverexpressionphosphoric diester hydrolasepreventprogramspromoterprotein expressionrenal agenesistargeted treatmenttherapeutic targettranscription factortranscriptome sequencingurinaryzygote
项目摘要
DESCRIPTION (provided by applicant): The purpose of this competitive renewal application is to continue our ongoing studies on hepatocyte nuclear factor-1β (HNF-1β) and its roles in the regulation of kidney-specific gene expression and cystic kidney diseases. HNF-1β is a DNA-binding transcription factor that regulates tissue-specific gene expression in the kidney and other epithelial organs. Mutations of HNF-1β produce renal developmental abnormalities including renal agenesis, hypoplasia, cystic dysplasia, and glomerulocystic kidney disease. To unravel the pathogenesis of these anomalies, we have produced mutant mice that develop phenotypes similar to affected humans. Kidney-specific inactivation of HNF-1β or expression of dominant-negative mutant HNF-1β in transgenic mice produces kidney cysts and renal failure. Analysis of these mutant mice has revealed that HNF-1β regulates the transcription of genes encoding ciliary proteins that are involved in human cystic kidney diseases. These findings demonstrate that HNF-1β plays a central role in cystic and developmental diseases of the kidney. To further elucidate the functions of HNF-1β, the proposed studies have two specific aims. The first aim is to understand how HNF-1β regulates Wnt signaling. Preliminary studies have shown that HNF-1β regulates genes that are involved in Wnt signaling, and inhibition of HNF-1β results in abnormal activation of the Wnt pathway, which may underlie cyst formation. Studies will be performed in mutant mice, cultured cells, and organ culture to elucidate the mechanism of activation of Wnt signaling. The second aim is to characterize microRNAs that are regulated by HNF-1β in the kidney. In addition to protein-coding genes, HNF-1β regulates the expression of microRNAs, which are small non-coding RNAs that regulate post-transcriptional gene expression. These findings have revealed a novel pathway by which HNF-1β regulates tissue-specific gene expression and kidney development. The functions of two families of microRNAs that are regulated by HNF-1β will be studied, and their target mRNA transcripts will be identified. Collectively, the proposed studies will advance our understanding of normal kidney development, unravel how mutations of HNF-1β produce kidney diseases, and identify potential therapeutic targets for cystic and developmental diseases of the kidney.
描述(由应用提供):这种竞争性更新应用的目的是继续我们对肝细胞核因子1β(HNF-1β)的持续研究及其在调节肾脏特异性基因表达和囊性肾脏疾病中的作用。 HNF-1β是一种DNA结合转录因子,可调节肾脏和其他上皮器官中组织特异性基因的表达。 HNF-1β的突变产生了肾脏发育异常,包括肾脏产生,发育不全,囊性发育异常和肾小球肾上腺肾脏疾病。为了揭示这些异常的发病机理,我们产生了突变小鼠,形成了与受影响人类相似的表型。转基因小鼠中HNF-1β的肾脏特异性失活或显性阴性突变体HNF-1β会产生肾脏囊肿和肾衰竭。对这些突变小鼠的分析表明,HNF-1β调节编码与人囊性肾脏疾病有关的纤毛蛋白的转录。这些发现表明,HNF-1β在肾脏疾病中起着核心作用。为了进一步阐明HNF-1β的功能,提出的研究具有两个具体的目的。第一个目的是了解HNF-1β如何调节WNT信号传导。初步研究表明,HNF-1β调节与Wnt信号传导有关的基因,而HNF-1β的抑制会导致Wnt途径异常激活,这可能是囊肿形成的基础。研究将在突变小鼠,培养细胞和器官培养中进行,以阐明Wnt信号的激活机理。第二个目的是表征肾脏中HNF-1β调控的microRNA。除蛋白质编码基因外,HNF-1β还调节了microRNA的表达,MicroRNA是调节转录后基因表达的小非编码RNA。这些发现揭示了一种新的途径,HNF-1β调节组织特异性基因表达和肾脏发育。将研究受HNF-1β调控的两个microRNA家族的功能,并将鉴定其目标mRNA转录本。总的来说,拟议的研究将提高我们对正常肾脏发育的理解,揭示HNF-1β突变如何产生肾脏疾病,并确定肾脏囊性和发育疾病的潜在治疗靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter Igarashi其他文献
Peter Igarashi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter Igarashi', 18)}}的其他基金
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7832043 - 财政年份:2009
- 资助金额:
$ 36.59万 - 项目类别:
MicroRNA-Based Therapeutics for Rare Cystic Kidney Diseases
基于 MicroRNA 的罕见囊性肾病治疗方法
- 批准号:
7936337 - 财政年份:2009
- 资助金额:
$ 36.59万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
7883980 - 财政年份:2009
- 资助金额:
$ 36.59万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8148016 - 财政年份:2007
- 资助金额:
$ 36.59万 - 项目类别:
UT southwestern O'Brien Kidney Research Core Center
德克萨斯大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8912182 - 财政年份:2007
- 资助金额:
$ 36.59万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
8097975 - 财政年份:2007
- 资助金额:
$ 36.59万 - 项目类别:
UT Southwestern O'Brien Kidney Research Core Center
德州大学西南奥布莱恩肾脏研究核心中心
- 批准号:
7325171 - 财政年份:2007
- 资助金额:
$ 36.59万 - 项目类别:
相似国自然基金
采用积分投影模型解析克隆生长对加拿大一枝黄花种群动态的影响
- 批准号:32301322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
山丘区农户生计分化对水保措施采用的影响及其调控对策
- 批准号:42377321
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
跨期决策中偏好反转的影响因素及作用机制:采用体验式实验范式的综合研究
- 批准号:72271190
- 批准年份:2022
- 资助金额:43 万元
- 项目类别:面上项目
农民合作社视角下组织支持、个人规范对农户化肥农药减量增效技术采用行为的影响机制研究
- 批准号:72103054
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
采用磁共振技术研究帕金森病蓝斑和黑质神经退变及其对大脑结构功能的影响
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
CCL5/CCR5轴在抑郁症中的性别特异性作用及其治疗意义
- 批准号:
10364861 - 财政年份:2022
- 资助金额:
$ 36.59万 - 项目类别:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
CCL5/CCR5轴在抑郁症中的性别特异性作用及其治疗意义
- 批准号:
10653682 - 财政年份:2022
- 资助金额:
$ 36.59万 - 项目类别:
Development of a Novel Cell Based PDE10A Assay for Antipsychotic Drug Discovery
开发用于抗精神病药物发现的新型细胞 PDE10A 检测方法
- 批准号:
8251094 - 财政年份:2011
- 资助金额:
$ 36.59万 - 项目类别:
Mechanisms of Antifibrotic Actions of Relaxin in the Liver
肝脏松弛素的抗纤维化作用机制
- 批准号:
8397584 - 财政年份:2011
- 资助金额:
$ 36.59万 - 项目类别:
Mechanisms of Antifibrotic Actions of Relaxin in the Liver
肝脏松弛素的抗纤维化作用机制
- 批准号:
8139602 - 财政年份:2011
- 资助金额:
$ 36.59万 - 项目类别: